艾滋病毒/艾滋病治疗资助系统,以支持印度尼西亚泗水市受艾滋病毒/艾滋病影响的人。

IF 0.9 4区 医学 Q4 HEALTH POLICY & SERVICES
Argyo Demartoto, Bhisma Murti, Siti Zunariyah
{"title":"艾滋病毒/艾滋病治疗资助系统,以支持印度尼西亚泗水市受艾滋病毒/艾滋病影响的人。","authors":"Argyo Demartoto,&nbsp;Bhisma Murti,&nbsp;Siti Zunariyah","doi":"10.1080/17290376.2020.1858946","DOIUrl":null,"url":null,"abstract":"<p><p>People Living with HIV/AIDS (PLWHA's) quality of life (QoL) is determined by the lifetime treatment sustainability. Republic of Indonesia Minister of Health's Decree Number 328 of 2003 stated that government subsidies the PLWHA's medication and treatment, despite not covering entire medication and treatment cost. The objective of research was to analyse the cost assumed by PLWHA in accessing HIV/AIDS treatment service in Surakarta, Indonesia. The target group in this case study was PLWHAs, and related stakeholders of medical treatment in one of Public Health Centers and a Public Hospital in Surakarta; AIDS Commission of Surakarta City; Solo Plus Peer Support Group and AIDS-Care NGO selected purposively. Data collection was carried out using observation, in-depth interview, and documentation. Method and data source triangulations were used to validate data that was then analysed using Grossman's Demand for Health Capital theory. The result of research showed that the sources of HIV/AIDS treatment cost were self-income, Social Insurance Administration Organization (BPJS) fund and Local Government subsidy. Admission and physican services are given for free to PLWHA because it has been paid by BPJS Fund or has been subsidied by Local Government. Otherwise, they should pay registration cost of IDR 50,000, in Public Hospital and IDR 75,000 in Private Hospital. Physician service costs IDR 50,000-IDR 200,000. VCT Counsellor costs IDR 35,000-IDR 150,000. Non-Subsidy ARV costs IDR 687,000. 1 bottle containing 60 TB meningitis drug capsules costs IDR 145,000 for 10-20 d use and maximally IDR 210,000, while herpes drug costs IDR 295,000. CD4 examination costs IDR 126,000-IDR 297,000, RNA Viral load IDR 1,275,000-IDR 1,471,000, Haematology IDR 60,000-IRD 90,000, Cholesterol and triglyceride IDR 100,000-IDR 250,000, and SGOT/SGPT IDR 100,000-IDR 200,000. There is monthly non-medical cost the patient should spend, including transportation cost to go to health centre, and food, beverage, and newspaper cost while waiting for the service. BPJS fund and local government subsidy relieved health economic burden of PLWHAs, so that the average HIV/AIDS treatment cost in PLWHAs was relatively low, less than 10% of expense. National Insurance System including BPJS fund and local government subsidy as the answer to the integration of HIV/AIDS treatment funding management into national insurance system had provided PLWHA a funding access involving prevention, care, support, and treatment, and mitigated the effect despite less optimum.</p>","PeriodicalId":45939,"journal":{"name":"Sahara J-Journal of Social Aspects of Hiv-Aids","volume":" ","pages":"1-16"},"PeriodicalIF":0.9000,"publicationDate":"2021-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1080/17290376.2020.1858946","citationCount":"3","resultStr":"{\"title\":\"HIV/AIDS treatment funding system to support the people affected by HIV/AIDS in Surakarta, Indonesia.\",\"authors\":\"Argyo Demartoto,&nbsp;Bhisma Murti,&nbsp;Siti Zunariyah\",\"doi\":\"10.1080/17290376.2020.1858946\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>People Living with HIV/AIDS (PLWHA's) quality of life (QoL) is determined by the lifetime treatment sustainability. Republic of Indonesia Minister of Health's Decree Number 328 of 2003 stated that government subsidies the PLWHA's medication and treatment, despite not covering entire medication and treatment cost. The objective of research was to analyse the cost assumed by PLWHA in accessing HIV/AIDS treatment service in Surakarta, Indonesia. The target group in this case study was PLWHAs, and related stakeholders of medical treatment in one of Public Health Centers and a Public Hospital in Surakarta; AIDS Commission of Surakarta City; Solo Plus Peer Support Group and AIDS-Care NGO selected purposively. Data collection was carried out using observation, in-depth interview, and documentation. Method and data source triangulations were used to validate data that was then analysed using Grossman's Demand for Health Capital theory. The result of research showed that the sources of HIV/AIDS treatment cost were self-income, Social Insurance Administration Organization (BPJS) fund and Local Government subsidy. Admission and physican services are given for free to PLWHA because it has been paid by BPJS Fund or has been subsidied by Local Government. Otherwise, they should pay registration cost of IDR 50,000, in Public Hospital and IDR 75,000 in Private Hospital. Physician service costs IDR 50,000-IDR 200,000. VCT Counsellor costs IDR 35,000-IDR 150,000. Non-Subsidy ARV costs IDR 687,000. 1 bottle containing 60 TB meningitis drug capsules costs IDR 145,000 for 10-20 d use and maximally IDR 210,000, while herpes drug costs IDR 295,000. CD4 examination costs IDR 126,000-IDR 297,000, RNA Viral load IDR 1,275,000-IDR 1,471,000, Haematology IDR 60,000-IRD 90,000, Cholesterol and triglyceride IDR 100,000-IDR 250,000, and SGOT/SGPT IDR 100,000-IDR 200,000. There is monthly non-medical cost the patient should spend, including transportation cost to go to health centre, and food, beverage, and newspaper cost while waiting for the service. BPJS fund and local government subsidy relieved health economic burden of PLWHAs, so that the average HIV/AIDS treatment cost in PLWHAs was relatively low, less than 10% of expense. National Insurance System including BPJS fund and local government subsidy as the answer to the integration of HIV/AIDS treatment funding management into national insurance system had provided PLWHA a funding access involving prevention, care, support, and treatment, and mitigated the effect despite less optimum.</p>\",\"PeriodicalId\":45939,\"journal\":{\"name\":\"Sahara J-Journal of Social Aspects of Hiv-Aids\",\"volume\":\" \",\"pages\":\"1-16\"},\"PeriodicalIF\":0.9000,\"publicationDate\":\"2021-12-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1080/17290376.2020.1858946\",\"citationCount\":\"3\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Sahara J-Journal of Social Aspects of Hiv-Aids\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1080/17290376.2020.1858946\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"HEALTH POLICY & SERVICES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Sahara J-Journal of Social Aspects of Hiv-Aids","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/17290376.2020.1858946","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"HEALTH POLICY & SERVICES","Score":null,"Total":0}
引用次数: 3

摘要

艾滋病毒/艾滋病感染者(PLWHA)的生活质量(QoL)取决于终生治疗的可持续性。印度尼西亚共和国卫生部长2003年第328号法令指出,政府补贴艾滋病患者的药品和治疗,尽管不支付全部药品和治疗费用。研究的目的是分析艾滋病毒/艾滋病感染者卫生组织在印度尼西亚苏拉卡塔获得艾滋病毒/艾滋病治疗服务方面承担的费用。本案例研究的目标群体是公共卫生机构,以及在一个公共卫生中心和泗水一所公立医院进行医疗的相关利益攸关方;泗水市艾滋病委员会;Solo Plus同伴互助小组和关爱艾滋病的非政府组织是有意选择的。数据收集采用观察法、深度访谈法和文献法。使用方法和数据源三角测量来验证数据,然后使用格罗斯曼的健康资本需求理论进行分析。研究结果表明,艾滋病治疗费用的来源主要为个人收入、社会保险经办机构(BPJS)基金和地方政府补贴。艾滋病规划署免费提供入院和医生服务,因为它是由艾滋病规划署基金支付的,或者是由地方政府补贴的。否则,在公立医院和私立医院分别支付注册费用50000印尼盾和75000印尼盾。医生服务费用为5万至20万印尼盾。VCT辅导员费用为35,000- 150,000印尼卢比。非补贴抗逆转录病毒药物费用为68.7万印尼盾。每瓶含有60粒结核性脑膜炎药物胶囊,使用10-20天的费用为14.5万印尼盾,最高为21万印尼盾,而疱疹药物的费用为29.5万印尼盾。CD4检查费用12.6万- 29.7万印尼盾,RNA病毒载量检查费用1,275,000- 1,471,000印尼盾,血液学检查费用60,000- 90,000印尼盾,胆固醇和甘油三酯检查费用100,000- 250,000印尼盾,SGOT/SGPT检查费用100,000- 200,000印尼盾。患者每月需要支付的非医疗费用包括前往保健中心的交通费,以及等待服务期间的食品、饮料和报纸费用。BPJS基金和地方政府补贴减轻了PLWHAs的卫生经济负担,使得PLWHAs的平均HIV/AIDS治疗费用较低,不到费用的10%。包括BPJS基金和地方政府补贴在内的国家保险制度作为将艾滋病毒/艾滋病治疗资金管理纳入国家保险制度的答案,为艾滋病毒/艾滋病感染者提供了包括预防、护理、支持和治疗在内的资金渠道,并减轻了效果,尽管效果并不理想。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

HIV/AIDS treatment funding system to support the people affected by HIV/AIDS in Surakarta, Indonesia.

HIV/AIDS treatment funding system to support the people affected by HIV/AIDS in Surakarta, Indonesia.

HIV/AIDS treatment funding system to support the people affected by HIV/AIDS in Surakarta, Indonesia.

HIV/AIDS treatment funding system to support the people affected by HIV/AIDS in Surakarta, Indonesia.

People Living with HIV/AIDS (PLWHA's) quality of life (QoL) is determined by the lifetime treatment sustainability. Republic of Indonesia Minister of Health's Decree Number 328 of 2003 stated that government subsidies the PLWHA's medication and treatment, despite not covering entire medication and treatment cost. The objective of research was to analyse the cost assumed by PLWHA in accessing HIV/AIDS treatment service in Surakarta, Indonesia. The target group in this case study was PLWHAs, and related stakeholders of medical treatment in one of Public Health Centers and a Public Hospital in Surakarta; AIDS Commission of Surakarta City; Solo Plus Peer Support Group and AIDS-Care NGO selected purposively. Data collection was carried out using observation, in-depth interview, and documentation. Method and data source triangulations were used to validate data that was then analysed using Grossman's Demand for Health Capital theory. The result of research showed that the sources of HIV/AIDS treatment cost were self-income, Social Insurance Administration Organization (BPJS) fund and Local Government subsidy. Admission and physican services are given for free to PLWHA because it has been paid by BPJS Fund or has been subsidied by Local Government. Otherwise, they should pay registration cost of IDR 50,000, in Public Hospital and IDR 75,000 in Private Hospital. Physician service costs IDR 50,000-IDR 200,000. VCT Counsellor costs IDR 35,000-IDR 150,000. Non-Subsidy ARV costs IDR 687,000. 1 bottle containing 60 TB meningitis drug capsules costs IDR 145,000 for 10-20 d use and maximally IDR 210,000, while herpes drug costs IDR 295,000. CD4 examination costs IDR 126,000-IDR 297,000, RNA Viral load IDR 1,275,000-IDR 1,471,000, Haematology IDR 60,000-IRD 90,000, Cholesterol and triglyceride IDR 100,000-IDR 250,000, and SGOT/SGPT IDR 100,000-IDR 200,000. There is monthly non-medical cost the patient should spend, including transportation cost to go to health centre, and food, beverage, and newspaper cost while waiting for the service. BPJS fund and local government subsidy relieved health economic burden of PLWHAs, so that the average HIV/AIDS treatment cost in PLWHAs was relatively low, less than 10% of expense. National Insurance System including BPJS fund and local government subsidy as the answer to the integration of HIV/AIDS treatment funding management into national insurance system had provided PLWHA a funding access involving prevention, care, support, and treatment, and mitigated the effect despite less optimum.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
2.00
自引率
0.00%
发文量
3
审稿时长
40 weeks
期刊介绍: The journal publishes contributions in English and French from all fields of social aspects of HIV/AIDS (care, support, behaviour change, behavioural surveillance, counselling, impact, mitigation, stigma, discrimination, prevention, treatment, adherence, culture, faith-based approaches, evidence-based intervention, health communication, structural and environmental intervention, financing, policy, media, etc).
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信